Back to Search
Start Over
Supplementary figure legend 2 from Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma
Supplementary figure legend 2 from Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Treatment significantly affects the circulating immune compartment.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....aaf8661283efc187904b5f5fcda67641
- Full Text :
- https://doi.org/10.1158/1078-0432.22481576.v1